Wieslaw Bal

Maria Sklodowska Curie National Research Institute Of Oncology Gliwice Branch, 
Gliwice, SL, PL 
Clinical Trials:Currently Recruiting for 1 Trial
Maria Sklodowska Curie National Research Institute Of Oncology Gliwice Branch, 
Gliwice, SL, PL 

Overview

Wieslaw Bal practices practicing medicine in Gliwice, Poland.

Their clinical expertise encompasses Melanoma, Adult Soft Tissue Sarcoma, Leukocytosis, Thrombectomy, and Rhizotomy.

They are actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 2 clinical trials.

Locations

Maria Sklodowska Curie National Research Institute Of Oncology Gliwice Branch, Gliwice, SL 44101, Poland
Other Locations
Cracow Branch, Krakow, MA, Poland
Gliwice Branch, Gliwice, SL, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effectiveness and Safety of Consolidative Brentuximab Vedotin (BV) Treatment Administered to Hodgkin's Lymphoma (HL) Patients That Had Undergone Autologous Stem Cell Transplant (ASCT). Prospective, Multicenter, Observational Study
Effectiveness and Safety of Consolidative Brentuximab Vedotin (BV) Treatment Administered to Hodgkin's Lymphoma (HL) Patients That Had Undergone Autologous Stem Cell Transplant (ASCT). Prospective, Multicenter, Observational Study
Enrollment Status: Recruiting
Publish Date: May 27, 2026
Intervention Type: Other
A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer
A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer
Enrollment Status: Terminated
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drugs: Bintrafusp Alfa, Gemcitabine, Cisplatin
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

23 Total Publications

Correction: Melanoma genomics- will we go beyond BRAF in clinics?
Correction: Melanoma genomics- will we go beyond BRAF in clinics?
Journal: Journal of cancer research and clinical oncology
Published: February 13, 2025

Frequently Asked Questions about Wieslaw Bal

Is Wieslaw Bal a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Wieslaw Bal is classified as an Experienced expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wieslaw Bal participate in research or clinical trials?

Yes. Wieslaw Bal has published 23 articles and abstracts on conditions like Melanoma. You can view a list of Wieslaw Bal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Bal's expertise for a condition
ConditionClose
        View All 8 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile